About Index Trending news
Lists
Pricing
SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$32,000,000
OrbiMed, Deerfield Capital Management, Federated Investors
Employees

Team size

10+
Locations
HQ
Headquarters
$30,000,000 Post-IPO equity
Drug Delivery Business , NoCamels

SteadyMed raises $30m for Trevyent commercial launch